Article Text

Download PDFPDF
Eosinophilic gastroenteritis in an adolescent male with history of chronic bullous disease
  1. Carol Stephanie C Tan-Lim1,
  2. Juan Miguel L Murillo2,
  3. Marysia Stella T Recto1 and
  4. Mary Anne R Castor1
  1. 1Division of Allergy and Immunology - Department of Pediatrics, Philippine General Hospital, Manila, Philippines
  2. 2Division of Pediatric Gastroenterology, Hepatology and Nutrition - Department of Pediatrics, Philippine General Hospital, Manila, Philippines
  1. Correspondence to Dr Carol Stephanie C Tan-Lim; cctan7{at}up.edu.ph

Abstract

Eosinophilic gastroenteritis is a rare inflammatory disorder of the gastrointestinal tract. Although commonly associated with allergic diseases, it is also rarely associated with autoimmune disorders. This case report describes a 17-year-old Filipino male with eosinophilic gastroenteritis, manifesting as abdominal pain, vomiting and diarrhoea. He had no allergic diseases, but he was previously diagnosed with chronic bullous disease. His symptoms improved with the initiation of corticosteroids. To date, this is the first case report of a patient with eosinophilic gastroenteritis and chronic bullous disease.

  • immunology
  • stomach and duodenum

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors CSCT-L: conceptualisation, writing, review and editing. JMM: data gathering and review. MSR: conceptualisation, review and editing. MARC: conceptualisation, review and editing.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests MSTR serves in the advisory board of A Menarini, Abbott Nutrition and Sanofi Aventis; a speaker for A Menarini, Abbott Nutrition, Abbott Pharma, Nutricia, RB Mead Johnson, Kalbe, Glenmark, Leo pharma, Mylan, Bayer, Natrapharm, AstraZeneca and Galderma; and received research grants from Galderma and Novartis. MARC served as a speaker and facilitator for a series of research workshop sponsored by Wyeth.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.